|
2025-04-14 |
2025-04-14 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
1,000
-0.5%
68.96
USD 27,584
|
1,000
-0.5%
|
68.96
|
USD 100,000
|
|
|
2025-03-20 |
2025-03-19 |
PS
Planned sale
|
Davis Krista
SVP, CHIEF HR OFFICER
Officer
|
1,866
-2.8%
65.00
USD 121,290
|
1,866
-2.8%
|
65.00
|
USD 121,290
|
|
|
2025-03-14 |
2025-03-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
400
-0.5%
63.33
USD 25,332
|
400
-0.5%
|
63.33
|
USD 25,332
|
|
|
2025-03-10 |
2025-03-07 |
PS
Planned sale
|
Davis Krista
SVP, CHIEF HR OFFICER
Officer
|
1,000
-1.5%
60.86
USD 60,860
|
1,000
-1.5%
|
60.86
|
USD 60,860
|
|
|
2025-03-07 |
2025-03-05 |
S
Sale
|
Gutwerg Ori
SVP, GENERICS
Officer
|
5,084
-5.1%
60.00
USD 305,040
|
5,084
-5.1%
|
60.00
|
USD 305,040
|
|
|
2025-03-07 |
2025-03-05 |
S
Sale
|
Gutwerg Ori
SVP, GENERICS
Officer
|
300
-0.3%
60.03
USD 18,009
|
300
-0.3%
|
60.03
|
USD 18,009
|
|
|
2025-02-24 |
2025-02-21 |
PS
Planned sale
|
Davis Krista
SVP, CHIEF HR OFFICER
Officer
|
1,000
-1.4%
60.20
USD 60,200
|
1,000
-1.4%
|
60.20
|
USD 60,200
|
|
|
2025-02-18 |
2025-02-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
400
-0.5%
59.54
USD 23,816
|
400
-0.5%
|
59.54
|
USD 23,816
|
|
|
2025-01-13 |
2025-01-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
400
-0.7%
53.92
USD 21,568
|
400
-0.7%
|
53.92
|
USD 21,568
|
|
|
2024-12-18 |
2024-12-17 |
S
Sale
|
CAREY STEPHEN P.
SVP & CFO
Officer
|
7,500
-4.6%
55.79
USD 418,425
|
7,500
-4.6%
|
55.79
|
USD 418,425
|
|
|
2024-12-16 |
2024-12-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
56.24
USD 14,060
|
250
-0.4%
|
56.24
|
USD 14,060
|
|
|
2024-12-12 |
2024-12-11 |
PS
Planned sale
|
Davis Krista
SVP, CHIEF HR OFFICER
Officer
|
1,000
-2.0%
60.00
USD 60,000
|
1,000
-2.0%
|
60.00
|
USD 60,000
|
|
|
2024-11-27 |
2024-11-26 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
3,481
-0.9%
58.30
USD 202,942
|
3,481
-0.9%
|
58.30
|
USD 202,942
|
|
|
2024-11-27 |
2024-11-26 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
30,000
-7.4%
57.95
USD 1,738,500
|
30,000
-7.4%
|
57.95
|
USD 1,738,500
|
|
|
2024-11-18 |
2024-11-15 |
S
Sale
|
Mutz Christopher
HEAD OF RARE DISEASE
Officer
|
6,500
-7.8%
57.70
USD 375,050
|
6,500
-7.8%
|
57.70
|
USD 375,050
|
|
|
2024-11-14 |
2024-11-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
61.36
USD 15,340
|
250
-0.4%
|
61.36
|
USD 15,340
|
|
|
2024-10-15 |
2024-10-14 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
57.19
USD 14,298
|
250
-0.4%
|
57.19
|
USD 14,298
|
|
|
2024-09-16 |
2024-09-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
56.82
USD 14,205
|
250
-0.4%
|
56.82
|
USD 14,205
|
|
|
2024-08-14 |
2024-08-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
59.62
USD 14,905
|
250
-0.4%
|
59.62
|
USD 14,905
|
|
|
2024-07-19 |
2024-07-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
2,743
-0.4%
62.00
USD 170,066
|
2,743
-0.4%
|
62.00
|
USD 170,066
|
|
|
2024-07-17 |
2024-07-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
14,257
-2.2%
63.16
USD 900,472
|
14,257
-2.2%
|
63.16
|
USD 900,472
|
|
|
2024-07-17 |
2024-07-16 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
22,000
-3.3%
64.27
USD 1,413,940
|
22,000
-3.3%
|
64.27
|
USD 1,413,940
|
|
|
2024-07-17 |
2024-07-15 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
11,000
-1.6%
63.38
USD 697,180
|
11,000
-1.6%
|
63.38
|
USD 697,180
|
|
|
2024-07-15 |
2024-07-12 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
64.91
USD 16,228
|
250
-0.4%
|
64.91
|
USD 16,228
|
|
|
2024-07-02 |
2024-07-01 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-9.4%
63.44
USD 1,268,800
|
20,000
-9.4%
|
63.44
|
USD 1,268,800
|
|
|
2024-06-24 |
2024-06-21 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
20,000
-2.8%
58.90
USD 1,178,000
|
20,000
-2.8%
|
58.90
|
USD 1,178,000
|
|
|
2024-06-20 |
2024-06-20 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
11,447
-1.6%
59.86
USD 685,217
|
11,447
-1.6%
|
59.86
|
USD 685,217
|
|
|
2024-06-20 |
2024-06-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,607
-1.5%
60.76
USD 644,481
|
10,607
-1.5%
|
60.76
|
USD 644,481
|
|
|
2024-06-20 |
2024-06-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
7,946
-1.1%
61.41
USD 487,964
|
7,946
-1.1%
|
61.41
|
USD 487,964
|
|
|
2024-06-14 |
2024-06-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
63.80
USD 15,950
|
250
-0.4%
|
63.80
|
USD 15,950
|
|
|
2024-06-06 |
2024-06-05 |
S
Sale
|
Gutwerg Ori
SVP, GENERICS
Officer
|
2,985
-3.7%
67.00
USD 199,995
|
2,985
-3.7%
|
67.00
|
USD 199,995
|
|
|
2024-06-06 |
2024-06-04 |
S
Sale
|
CAREY STEPHEN P.
SVP & CFO
Officer
|
5,000
-3.0%
63.58
USD 317,900
|
5,000
-3.0%
|
63.58
|
USD 317,900
|
|
|
2024-06-04 |
2024-06-03 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-8.6%
64.41
USD 1,288,200
|
20,000
-8.6%
|
64.41
|
USD 1,288,200
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
Mutz Christopher
HEAD OF RARE DISEASE
Officer
|
2,000
-2.3%
61.61
USD 123,220
|
2,000
-2.3%
|
61.61
|
USD 123,220
|
|
|
2024-05-21 |
2024-05-20 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
12,855
-1.7%
61.81
USD 794,568
|
12,855
-1.7%
|
61.81
|
USD 794,568
|
|
|
2024-05-17 |
2024-05-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
5,836
-0.8%
62.09
USD 362,357
|
5,836
-0.8%
|
62.09
|
USD 362,357
|
|
|
2024-05-17 |
2024-05-16 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
16,459
-2.1%
63.84
USD 1,050,743
|
16,459
-2.1%
|
63.84
|
USD 1,050,743
|
|
|
2024-05-17 |
2024-05-16 |
S
Sale
|
TANNENBAUM RENEE P
Non-Executive Director
|
2,000
-9.9%
63.87
USD 127,740
|
2,000
-9.9%
|
63.87
|
USD 127,740
|
|
|
2024-05-17 |
2024-05-15 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
14,850
-1.9%
65.86
USD 978,021
|
14,850
-1.9%
|
65.86
|
USD 978,021
|
|
|
2024-05-16 |
2024-05-14 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
16,669
-4.2%
66.10
USD 1,101,821
|
16,669
-4.2%
|
66.10
|
USD 1,101,821
|
|
|
2024-05-13 |
2024-05-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
67.69
USD 16,923
|
250
-0.4%
|
67.69
|
USD 16,923
|
|
|
2024-05-03 |
2024-05-01 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-7.9%
66.62
USD 1,332,400
|
20,000
-7.9%
|
66.62
|
USD 1,332,400
|
|
|
2024-04-22 |
2024-04-19 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
16,809
-2.1%
65.17
USD 1,095,443
|
16,809
-2.1%
|
65.17
|
USD 1,095,443
|
|
|
2024-04-22 |
2024-04-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,423
-1.3%
64.98
USD 677,287
|
10,423
-1.3%
|
64.98
|
USD 677,287
|
|
|
2024-04-17 |
2024-04-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
9,520
-1.2%
65.40
USD 622,608
|
9,520
-1.2%
|
65.40
|
USD 622,608
|
|
|
2024-04-17 |
2024-04-16 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
5,834
-0.7%
66.20
USD 386,211
|
5,834
-0.7%
|
66.20
|
USD 386,211
|
|
|
2024-04-17 |
2024-04-15 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
7,414
-0.9%
66.33
USD 491,771
|
7,414
-0.9%
|
66.33
|
USD 491,771
|
|
|
2024-04-15 |
2024-04-12 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
67.79
USD 16,948
|
250
-0.4%
|
67.79
|
USD 16,948
|
|
|
2024-04-02 |
2024-04-01 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-7.3%
67.25
USD 1,345,000
|
20,000
-7.3%
|
67.25
|
USD 1,345,000
|
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
66.54
USD 16,635
|
250
-0.4%
|
66.54
|
USD 16,635
|
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-6.8%
65.81
USD 1,316,200
|
20,000
-6.8%
|
65.81
|
USD 1,316,200
|
|
|
2024-03-11 |
2024-03-11 |
S
Sale
|
CAREY STEPHEN P.
SVP & CFO
Officer
|
7,787
-4.2%
65.55
USD 510,438
|
7,787
-4.2%
|
65.55
|
USD 510,438
|
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,000
-1.2%
67.17
USD 671,700
|
10,000
-1.2%
|
67.17
|
USD 671,700
|
|
|
2024-03-08 |
2024-03-08 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
16,292
-3.8%
67.13
USD 1,093,682
|
16,292
-3.8%
|
67.13
|
USD 1,093,682
|
|
|
2024-03-07 |
2024-03-07 |
S
Sale
|
Marken James G.
SVP OPS & PROD DEV
Officer
|
24,338
-16.4%
66.37
USD 1,615,313
|
24,338
-16.4%
|
66.37
|
USD 1,615,313
|
|
|
2024-03-07 |
2024-03-07 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
15,085
-1.8%
66.35
USD 1,000,890
|
15,085
-1.8%
|
66.35
|
USD 1,000,890
|
|
|
2024-03-08 |
2024-03-06 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
28,965
-6.1%
65.52
USD 1,897,787
|
28,965
-6.1%
|
65.52
|
USD 1,897,787
|
|
|
2024-03-07 |
2024-03-06 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
14,822
-1.7%
65.47
USD 970,396
|
14,822
-1.7%
|
65.47
|
USD 970,396
|
|
|
2024-03-07 |
2024-03-05 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,093
-1.1%
65.35
USD 659,578
|
10,093
-1.1%
|
65.35
|
USD 659,578
|
|
|
2024-03-06 |
2024-03-05 |
S
Sale
|
Mutz Christopher
HEAD OF RARE DISEASE
Officer
|
5,000
-5.4%
66.00
USD 330,000
|
5,000
-5.4%
|
66.00
|
USD 330,000
|
|
|
2024-03-06 |
2024-03-04 |
S
Sale
|
Pera Antonio R
Non-Executive Director
|
7,000
-20.8%
65.20
USD 456,400
|
7,000
-20.8%
|
65.20
|
USD 456,400
|
|
|
2024-02-13 |
2024-02-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.7%
56.04
USD 14,010
|
250
-0.7%
|
56.04
|
USD 14,010
|
|
|
2024-01-23 |
2024-01-23 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
15,000
-1.7%
56.44
USD 846,600
|
15,000
-1.7%
|
56.44
|
USD 846,600
|
|
|
2024-01-23 |
2024-01-22 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
5,692
-0.6%
55.95
USD 318,467
|
5,692
-0.6%
|
55.95
|
USD 318,467
|
|
|
2024-01-23 |
2024-01-19 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
4,524
-0.5%
55.57
USD 251,399
|
4,524
-0.5%
|
55.57
|
USD 251,399
|
|
|
2024-01-18 |
2024-01-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
9,784
-1.1%
55.30
USD 541,055
|
9,784
-1.1%
|
55.30
|
USD 541,055
|
|
|
2024-01-18 |
2024-01-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,000
-1.1%
55.11
USD 551,100
|
10,000
-1.1%
|
55.11
|
USD 551,100
|
|
|
2024-01-18 |
2024-01-16 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
5,000
-0.5%
55.63
USD 278,150
|
5,000
-0.5%
|
55.63
|
USD 278,150
|
|
|
2024-01-16 |
2024-01-12 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.7%
56.43
USD 14,108
|
250
-0.7%
|
56.43
|
USD 14,108
|
|
|
2023-12-19 |
2023-12-19 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
25,000
-2.6%
52.65
USD 1,316,250
|
25,000
-2.6%
|
52.65
|
USD 1,316,250
|
|
|
2023-12-19 |
2023-12-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
13,026
-1.3%
52.44
USD 683,083
|
13,026
-1.3%
|
52.44
|
USD 683,083
|
|
|
2023-12-19 |
2023-12-15 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
11,974
-1.2%
52.44
USD 627,917
|
11,974
-1.2%
|
52.44
|
USD 627,917
|
|
|
2023-12-11 |
2023-12-11 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.7%
49.21
USD 12,303
|
250
-0.7%
|
49.21
|
USD 12,303
|
|
|
2023-11-20 |
2023-11-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
13,000
-1.3%
51.00
USD 663,000
|
13,000
-1.3%
|
51.00
|
USD 663,000
|
|
|
2023-11-16 |
2023-11-16 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
6,448
-0.6%
51.66
USD 333,104
|
6,448
-0.6%
|
51.66
|
USD 333,104
|
|
